IRIDEX CORP Increase (Decrease) in Due to Related Parties
IRIDEX CORP (IRIX) reported Increase (Decrease) in Due to Related Parties of $42.00 thousand for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2026-08-18
- IRIDEX CORP increase (decrease) in due to related parties for the quarter ending 2026-07-04 was -$142.00K.
- IRIDEX CORP increase (decrease) in due to related parties for the quarter ending 2026-04-04 was $184.00K, a 260.78% increase year-over-year.
- IRIDEX CORP increase (decrease) in due to related parties for the quarter ending 2026-01-03 was -$96.00K, a 420.00% decline year-over-year.
- IRIDEX CORP increase (decrease) in due to related parties for the quarter ending 2025-09-27 was -$222.00K.
- IRIDEX CORP increase (decrease) in due to related parties for fiscal 2026 was -$492.00K, a 229.13% decline from fiscal 2024.
- IRIDEX CORP increase (decrease) in due to related parties for fiscal 2024 was $381.00K, a 78.87% increase from fiscal 2023.
- IRIDEX CORP increase (decrease) in due to related parties for fiscal 2023 was $213.00K.
- IRIDEX CORP increase (decrease) in due to related parties for fiscal 2022 was -$612.00K, a 197.61% decline from fiscal 2022.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2026-07-04 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | $42.00K 10-Q · filed 2026-08-18 | -$54.00K derived: sum of 3 quarters · filed 2026-08-18 | -$276.00K derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-04-04 | $184.00K 10-Q · filed 2026-05-19 | $88.00K derived: sum of 2 quarters · filed 2026-05-19 | -$134.00K derived: sum of 3 quarters · filed 2026-05-19 | -$359.00K derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-01-03 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-02 | -$318.00K derived: sum of 2 quarters · filed 2026-04-02 | -$543.00K derived: sum of 3 quarters · filed 2026-08-18 | -$492.00K 10-K · filed 2026-04-02 |
| 2025-09-27 | -$222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$447.00K derived: sum of 2 quarters · filed 2026-08-18 | -$396.00K 10-Q · filed 2025-11-12 | -$366.00K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-06-28 | -$225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | -$174.00K 10-Q · filed 2026-08-18 | -$144.00K derived: sum of 3 quarters · filed 2026-08-18 | -$184.00K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-29 | $51.00K 10-Q · filed 2026-05-19 | $81.00K derived: sum of 2 quarters · filed 2026-05-19 | $41.00K derived: sum of 3 quarters · filed 2026-05-19 | $350.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-28 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-02 | -$10.00K derived: sum of 2 quarters · filed 2026-04-02 | $299.00K derived: sum of 3 quarters · filed 2026-04-02 | $381.00K 10-K · filed 2026-04-02 |
| 2024-09-28 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $269.00K derived: sum of 2 quarters · filed 2025-11-12 | $351.00K 10-Q · filed 2025-11-12 | $576.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-29 | $309.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $391.00K 10-Q · filed 2025-08-12 | $616.00K derived: sum of 3 quarters · filed 2025-08-12 | $485.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-30 | $82.00K 10-Q · filed 2025-05-13 | $307.00K derived: sum of 2 quarters · filed 2025-05-13 | $176.00K derived: sum of 3 quarters · filed 2025-05-13 | $187.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-30 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $94.00K derived: sum of 2 quarters · filed 2025-03-27 | $105.00K derived: sum of 3 quarters · filed 2025-03-27 | $213.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$120.00K derived: sum of 2 quarters · filed 2024-11-12 | -$12.00K 10-Q · filed 2024-11-12 | -$98.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-07-01 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $119.00K 10-Q · filed 2024-08-08 | $33.00K derived: sum of 3 quarters · filed 2024-08-08 | -$46.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-04-01 | $108.00K 10-Q · filed 2024-05-14 | $22.00K derived: sum of 2 quarters · filed 2024-05-14 | -$57.00K derived: sum of 3 quarters · filed 2024-05-14 | -$776.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$165.00K derived: sum of 2 quarters · filed 2024-03-29 | -$884.00K derived: sum of 3 quarters · filed 2024-03-29 | -$612.00K 10-K · filed 2024-03-29 |
| 2022-10-01 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | -$798.00K derived: sum of 2 quarters · filed 2023-11-20 | -$526.00K 10-Q · filed 2023-11-20 | -$413.00K derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-07-02 | -$719.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$447.00K 10-Q · filed 2022-08-15 | -$334.00K derived: sum of 3 quarters · filed 2023-08-10 | $141.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-04-02 | $272.00K 10-Q · filed 2023-05-11 | $385.00K derived: sum of 2 quarters · filed 2023-05-11 | $860.00K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2022-01-01 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $588.00K derived: sum of 2 quarters · filed 2023-03-09 | $627.00K 10-K · filed 2023-03-09 | |
| 2021-10-02 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $514.00K 10-Q · filed 2022-11-10 | ||
| 2021-07-03 | $39.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |